FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022338473> ?p ?o ?g. }

• W2022338473 endingPage "693" @default.
• W2022338473 startingPage "686" @default.
• W2022338473 abstract "Heart failure (HF) is a common pathological end point for several cardiac diseases. Despite reasonable achievements in pharmacological, electrophysiological and surgical treatments, prognosis for chronic HF remains poor. Modern therapies are generally symptom oriented and do not currently address specific intracellular molecular signaling abnormalities. Therefore, new and innovative therapeutic approaches are warranted and, ideally, these could at least complement established therapeutic options if not replace them. Gene therapy has potential to serve in this regard in HF as vectors can be directed toward diseased myocytes and directly target intracellular signaling abnormalities. Within this review, we will dissect the adrenergic system contributing to HF development and progression with special emphasis on G-protein-coupled receptor kinase 2 (GRK2). The levels and activity of GRK2 are increased in HF and we and others have demonstrated that this kinase is a major molecular culprit in HF. We will cover the evidence supporting gene therapy directed against myocardial as well as adrenal GRK2 to improve the function and structure of the failing heart and how these strategies may offer complementary and synergistic effects with the existing HF mainstay therapy of β-adrenergic receptor antagonism." @default.
• W2022338473 created "2016-06-24" @default.
• W2022338473 creator A5004513454 @default.
• W2022338473 creator A5024068118 @default.
• W2022338473 creator A5040353908 @default.
• W2022338473 creator A5049262839 @default.
• W2022338473 creator A5075648082 @default.
• W2022338473 creator A5080946575 @default.
• W2022338473 creator A5091118033 @default.
• W2022338473 date "2012-02-16" @default.
• W2022338473 modified "2023-09-27" @default.
• W2022338473 title "Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade" @default.
• W2022338473 cites W1966619635 @default.
• W2022338473 cites W1973138130 @default.
• W2022338473 cites W1980819618 @default.
• W2022338473 cites W1981731045 @default.
• W2022338473 cites W1988989702 @default.
• W2022338473 cites W1990787076 @default.
• W2022338473 cites W2011309117 @default.
• W2022338473 cites W2018493611 @default.
• W2022338473 cites W2021006625 @default.
• W2022338473 cites W2027565281 @default.
• W2022338473 cites W2028125482 @default.
• W2022338473 cites W2029913374 @default.
• W2022338473 cites W2034315036 @default.
• W2022338473 cites W2040377097 @default.
• W2022338473 cites W2043890741 @default.
• W2022338473 cites W2044448441 @default.
• W2022338473 cites W2049365481 @default.
• W2022338473 cites W2049445541 @default.
• W2022338473 cites W2050839858 @default.
• W2022338473 cites W2053191575 @default.
• W2022338473 cites W2053599848 @default.
• W2022338473 cites W2055375040 @default.
• W2022338473 cites W2059308387 @default.
• W2022338473 cites W2066221339 @default.
• W2022338473 cites W2066243813 @default.
• W2022338473 cites W2066564095 @default.
• W2022338473 cites W2066920501 @default.
• W2022338473 cites W2078748771 @default.
• W2022338473 cites W2087603118 @default.
• W2022338473 cites W2094065595 @default.
• W2022338473 cites W2107224032 @default.
• W2022338473 cites W2110557028 @default.
• W2022338473 cites W2123248700 @default.
• W2022338473 cites W2123490348 @default.
• W2022338473 cites W2124114189 @default.
• W2022338473 cites W2128688403 @default.
• W2022338473 cites W2131120771 @default.
• W2022338473 cites W2136978596 @default.
• W2022338473 cites W2139918394 @default.
• W2022338473 cites W2140675350 @default.
• W2022338473 cites W2142377849 @default.
• W2022338473 cites W2144964986 @default.
• W2022338473 cites W2145827465 @default.
• W2022338473 cites W2149239576 @default.
• W2022338473 cites W2150335297 @default.
• W2022338473 cites W2152515988 @default.
• W2022338473 cites W2155007822 @default.
• W2022338473 cites W2155432244 @default.
• W2022338473 cites W2163463871 @default.
• W2022338473 cites W2166068071 @default.
• W2022338473 cites W2171092233 @default.
• W2022338473 cites W2172010440 @default.
• W2022338473 cites W2312735671 @default.
• W2022338473 cites W2338638760 @default.
• W2022338473 cites W4297631428 @default.
• W2022338473 doi "https://doi.org/10.1038/gt.2012.9" @default.
• W2022338473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22336718" @default.
• W2022338473 hasPublicationYear "2012" @default.
• W2022338473 type Work @default.
• W2022338473 sameAs 2022338473 @default.
• W2022338473 citedByCount "23" @default.
• W2022338473 countsByYear W20223384732012 @default.
• W2022338473 countsByYear W20223384732013 @default.
• W2022338473 countsByYear W20223384732014 @default.
• W2022338473 countsByYear W20223384732016 @default.
• W2022338473 countsByYear W20223384732017 @default.
• W2022338473 countsByYear W20223384732018 @default.
• W2022338473 countsByYear W20223384732019 @default.
• W2022338473 countsByYear W20223384732020 @default.
• W2022338473 crossrefType "journal-article" @default.
• W2022338473 hasAuthorship W2022338473A5004513454 @default.
• W2022338473 hasAuthorship W2022338473A5024068118 @default.
• W2022338473 hasAuthorship W2022338473A5040353908 @default.
• W2022338473 hasAuthorship W2022338473A5049262839 @default.
• W2022338473 hasAuthorship W2022338473A5075648082 @default.
• W2022338473 hasAuthorship W2022338473A5080946575 @default.
• W2022338473 hasAuthorship W2022338473A5091118033 @default.
• W2022338473 hasBestOaLocation W20223384731 @default.
• W2022338473 hasConcept C104317684 @default.
• W2022338473 hasConcept C111599444 @default.
• W2022338473 hasConcept C126322002 @default.
• W2022338473 hasConcept C135285700 @default.
• W2022338473 hasConcept C169760540 @default.
• W2022338473 hasConcept C170493617 @default.
• W2022338473 hasConcept C2778198053 @default.
• W2022338473 hasConcept C2778468042 @default.

• next